On February 1, 2023, the FTC announced a proposed $1.5 million settlement with GoodRx Holdings, based on alleged violations of the Federal Trade Commission Act (“FTC Act”) and Health Breach Notification Rule (“HBNR”) for using advertising technologies on its websites and mobile app that resulted in the unauthorized disclosure of consumers’ personal and health information to advertisers and other third parties. On the same day, the U.S. Department of Justice, acting on behalf of the FTC, filed a Complaint and Proposed Stipulated Order detailing the FTC’s allegations and the terms of the proposed settlement.
Blog Editors
Recent Updates
- Video: PAGA in California, NLRB Authority, New Employment Laws in 2025 - Employment Law This Week
- New York’s Reproductive Health Handbook Notice Requirement Reinstated
- Video: Employment Law in 2025: A Look Ahead - Employment Law This Week
- Two New Laws Provide Employer Relief for ACA Reporting
- The EEOC and Wearable Tech: Balancing Innovation and Compliance